Back to Trades
Hecht Beth
See RemarksCIK 0001652410
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2025–2026
Across 9 filings between 2025–2026, Hecht Beth, See Remarks, has disclosed $3.5M in transactions — all concentrated in Xeris Biopharma Holdings, Inc. (XERS). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.0M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 2 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $133.9K |
| Jun 2 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $101.0K |
| May 1 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $103.8K |
| Apr 3 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $99.9K |
| Mar 4 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $104.1K |
| Feb 2 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $124.1K |
| Jan 5 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $123.8K |
| Dec 2 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $116.8K |
| Nov 13 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | $123.3K |
9 filings